LivaNova Group - רווח נקי למניה אחת בשנים עשר החודשים האחרונים LIVN

LivaNova PLC management is optimizing its medtech portfolio, prioritizing neuromodulation innovations to drive margin growth. The 12-month annual growth in earnings per share reflects the dynamics of these processes, where 188.60 determines the current value of the metric. Revenue stability is supported by diversification into cardiac surgery and global sales. Product assembly relies on a network of certified contractors, eliminating dependence on specific suppliers.
פילוחי מדדים פיננסיים ומדדי שוק עבור LivaNova PLC (LIVN)

This indicator measures the rate of change in net earnings per share over a rolling year, identifying deviations of current returns from historical extremes and eliminating time lags between quarterly reports. By analyzing the annual growth of EPS TTM, an investor can assess the effectiveness of the organic development of LivaNova PLC during a period of abandoned expansion and internal asset optimization.